These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 30139761

  • 1. Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
    Chaithra VH, Jacob SP, Lakshmikanth CL, Sumanth MS, Abhilasha KV, Chen CH, Thyagarajan A, Sahu RP, Travers JB, McIntyre TM, Kemparaju K, Marathe GK.
    J Lipid Res; 2018 Nov; 59(11):2063-2074. PubMed ID: 30139761
    [Abstract] [Full Text] [Related]

  • 2. Effect of acyl and alkyl analogs of platelet-activating factor on inflammatory signaling.
    Marathe GK, Chaithra VH, Ke LY, Chen CH.
    Prostaglandins Other Lipid Mediat; 2020 Dec; 151():106478. PubMed ID: 32711129
    [Abstract] [Full Text] [Related]

  • 3. Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolase.
    Liu J, Chen R, Marathe GK, Febbraio M, Zou W, McIntyre TM.
    Circ Res; 2011 Feb 18; 108(4):469-77. PubMed ID: 21183738
    [Abstract] [Full Text] [Related]

  • 4. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways.
    Howard KM, Abdel-Al M, Ditmyer M, Patel N.
    Inflamm Res; 2011 Aug 18; 60(8):735-44. PubMed ID: 21432021
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L.
    Hum Mol Genet; 2004 Jul 01; 13(13):1341-51. PubMed ID: 15115767
    [Abstract] [Full Text] [Related]

  • 6. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M, Sugatani J, Ino M, Shimura M, Akiyama M, Yamazaki R, Suzuki Y, Miwa M.
    Am J Physiol; 1998 Jan 01; 274(1):C47-57. PubMed ID: 9458712
    [Abstract] [Full Text] [Related]

  • 7. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo.
    Kono N, Inoue T, Yoshida Y, Sato H, Matsusue T, Itabe H, Niki E, Aoki J, Arai H.
    J Biol Chem; 2008 Jan 18; 283(3):1628-1636. PubMed ID: 18024956
    [Abstract] [Full Text] [Related]

  • 8. Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis.
    Gill P, Jindal NL, Jagdis A, Vadas P.
    J Allergy Clin Immunol; 2015 Jun 18; 135(6):1424-32. PubMed ID: 26051949
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction of platelet-activating factor with rat hepatocytes: uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation.
    Svetlov SI, Howard KM, Miwa M, Flickinger BD, Olson MS.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):113-22. PubMed ID: 8615681
    [Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.
    Tsoukatos DC, Brochériou I, Moussis V, Panopoulou CP, Christofidou ED, Koussissis S, Sismanidis S, Ninio E, Siminelakis S.
    J Lipid Res; 2008 Oct 01; 49(10):2240-9. PubMed ID: 18587071
    [Abstract] [Full Text] [Related]

  • 13. Anti-apoptotic actions of the platelet-activating factor acetylhydrolase I alpha2 catalytic subunit.
    Bonin F, Ryan SD, Migahed L, Mo F, Lallier J, Franks DJ, Arai H, Bennett SA.
    J Biol Chem; 2004 Dec 10; 279(50):52425-36. PubMed ID: 15456758
    [Abstract] [Full Text] [Related]

  • 14. Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids.
    Marathe GK, Silva AR, de Castro Faria Neto HC, Tjoelker LW, Prescott SM, Zimmerman GA, McIntyre TM.
    J Lipid Res; 2001 Sep 10; 42(9):1430-7. PubMed ID: 11518762
    [Abstract] [Full Text] [Related]

  • 15. PAF levels and PAF-AH activities in placentas from normal and preeclamptic pregnancies.
    Gu Y, Burlison SA, Wang Y.
    Placenta; 2006 Sep 10; 27(6-7):744-9. PubMed ID: 16122793
    [Abstract] [Full Text] [Related]

  • 16. Receptor-dependent metabolism of platelet-activating factor in murine macrophages.
    Ohshima N, Ishii S, Izumi T, Shimizu T.
    J Biol Chem; 2002 Mar 22; 277(12):9722-7. PubMed ID: 11786559
    [Abstract] [Full Text] [Related]

  • 17. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase.
    Kuijpers TW, van den Berg JM, Tool AT, Roos D.
    Clin Exp Immunol; 2001 Mar 22; 123(3):412-20. PubMed ID: 11298128
    [Abstract] [Full Text] [Related]

  • 18. Determination of specific receptor sites for platelet activating factor in bovine neutrophils.
    Burgos RA, Hidalgo MA, Matthei SM, Hermosilla R, Folch H, Hancke JL.
    Am J Vet Res; 2004 May 22; 65(5):628-36. PubMed ID: 15141884
    [Abstract] [Full Text] [Related]

  • 19. Binding and metabolism of platelet-activating factor (PAF) by isolated rat type II pneumonocytes.
    Eguchi H, Frenkel RA, Johnston JM.
    Arch Biochem Biophys; 1994 Feb 01; 308(2):426-31. PubMed ID: 8109971
    [Abstract] [Full Text] [Related]

  • 20. Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure.
    Sharma J, Young DM, Marentette JO, Rastogi P, Turk J, McHowat J.
    Am J Physiol Lung Cell Mol Physiol; 2012 Jan 01; 302(1):L47-55. PubMed ID: 21984569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.